The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England - but only for ...

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

The drug will only be made available on the NHS for patients whose medical or surgical treatment for endometriosis has failed ...

The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...

A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

Massachusetts residents are sick and tired of paying taxes, and a new poll shows strong opposition from likely voters on Gov.

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

The business conducted clinical trials of new potential drug treatments on behalf of sponsor companies seeking approval from ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...